Home
COCP
COCP News

Latest Cocrystal Pharma Inc. (COCP) News on November 18, 2024

November 2024 US Exchange Standouts: Promising Penny Stocks

Simply Wall St.

3 days ago

November 2024 US Exchange Standouts: Promising Penny Stocks

Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

GlobeNewswire

5 days ago

Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Cocrystal Pharma’s Co-CEOs Highlight Pioneering Approach to Antiviral Drug Candidates Targeting Influenza and Coronaviruses as Fall Flu and COVID Season Begins

GlobeNewswire

18 days ago

Cocrystal Pharma’s Co-CEOs Highlight Pioneering Approach to Antiviral Drug Candidates Targeting Influenza and Coronaviruses as Fall Flu and COVID Season Begins

Here's Why We're Watching Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Situation

Simply Wall St.

a month ago

Here's Why We're Watching Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Situation

Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose Cohorts

GlobeNewswire

2 months ago

Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose Cohorts

Cocrystal Pharma to Highlight Near-term Clinical Milestones During Presentations at Two Upcoming Investment Conferences

GlobeNewswire

3 months ago

Cocrystal Pharma to Highlight Near-term Clinical Milestones During Presentations at Two Upcoming Investment Conferences

Zacks Small Cap Research

3 months ago

COCP: Topline Results from Phase 2a Study of CC-42344 in 2H24…

ACCESSWIRE

3 months ago

CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event

Cocrystal Pharma Reports Second Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

GlobeNewswire

3 months ago

Cocrystal Pharma Reports Second Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Zacks Small Cap Research

4 months ago

COCP: Phase 1 Single-Ascending Dose Cohort of CDI-988 Shows it is Safe and Well Tolerated…

Cocrystal Pharma Reports Favorable Results from Single-Ascending Dose Cohorts of Phase 1 Study with CDI-988, its Oral Pan-Viral Norovirus/Coronavirus Protease Inhibitor

GlobeNewswire

4 months ago

Cocrystal Pharma Reports Favorable Results from Single-Ascending Dose Cohorts of Phase 1 Study with CDI-988, its Oral Pan-Viral Norovirus/Coronavirus Protease Inhibitor

COCP: CC-42344 Shows In Vitro Activity Against Avian Influenza A (H5N1)…

Zacks Small Cap Research

5 months ago

COCP: CC-42344 Shows In Vitro Activity Against Avian Influenza A (H5N1)…

New Broad-Spectrum Antiviral Currently in a Phase 2a Clinical Trial in Influenza A may be Effective Against the H5N1 Avian Influenza Strain Identified in Humans Exposed to Infected Dairy Cows

GlobeNewswire

5 months ago

New Broad-Spectrum Antiviral Currently in a Phase 2a Clinical Trial in Influenza A may be Effective Against the H5N1 Avian Influenza Strain Identified in Humans Exposed to Infected Dairy Cows

Better AI Stock: Palantir vs. Snowflake

Motley Fool

5 months ago

Better AI Stock: Palantir vs. Snowflake

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

Motley Fool

5 months ago

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

BigBear.ai Stock: Buy, Sell, or Hold?

Motley Fool

5 months ago

BigBear.ai Stock: Buy, Sell, or Hold?

Indonesia's first Olympic gymnast encourages others to 'dream higher'

AFP

5 months ago

Indonesia's first Olympic gymnast encourages others to 'dream higher'

Where Will CrowdStrike Stock Be in 1 Year?

Motley Fool

5 months ago

Where Will CrowdStrike Stock Be in 1 Year?

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

GuruFocus.com

5 months ago

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

GuruFocus.com

5 months ago

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)

Simply Wall St.

5 months ago

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)

Cocrystal Pharma, Inc. (COCP) Now Trades Above Golden Cross: Time to Buy?

Zacks

5 months ago

Cocrystal Pharma, Inc. (COCP) Now Trades Above Golden Cross: Time to Buy?

Zacks Small Cap Research

6 months ago

COCP: Enrollment Complete in Phase 2a Human Challenge Trial of CC-42344…

Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

GlobeNewswire

6 months ago

Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza

GlobeNewswire

7 months ago

Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza

COCP: Topline Data for Influenza A and Dual Coronavirus/Norovirus Programs Expected in 2024; Model Revision Leads to Valuation of $6 Per Share…

Zacks Small Cap Research

7 months ago

COCP: Topline Data for Influenza A and Dual Coronavirus/Norovirus Programs Expected in 2024; Model Revision Leads to Valuation of $6 Per Share…

Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

GlobeNewswire

8 months ago

Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A

GlobeNewswire

8 months ago

Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A

ACCESSWIRE

8 months ago

Cocrystal Pharma Discusses Antiviral Therapeutics' Clinical Development and 2024 Value Catalysts in New CEO Video Interview on Planet MicroCap

Zacks Small Cap Research

9 months ago

COCP: Cocrystal Pharma provides updates on its clinical programs.

SU Group Holdings Reports 20% Revenue Growth For Fiscal Year 2023

PR Newswire

10 months ago

SU Group Holdings Reports 20% Revenue Growth For Fiscal Year 2023

5E Advanced Materials, Inc. Provides Update Confirming Boric Acid and Lithium at 5E Boron Americas Complex

GlobeNewswire

10 months ago

5E Advanced Materials, Inc. Provides Update Confirming Boric Acid and Lithium at 5E Boron Americas Complex

Texas Municipality Expands Use of Knightscope Emergency Communications

Business Wire

10 months ago

Texas Municipality Expands Use of Knightscope Emergency Communications

Jayud Announces Entry into Agreements to Acquire Two International Logistics Companies, Embarking on an Acquisition Strategy to Expand Service Offerings and Geographic Footprint

PR Newswire

10 months ago

Jayud Announces Entry into Agreements to Acquire Two International Logistics Companies, Embarking on an Acquisition Strategy to Expand Service Offerings and Geographic Footprint

POET Technologies Provides Update on Non-Brokered Private Placement

GlobeNewswire

10 months ago

POET Technologies Provides Update on Non-Brokered Private Placement

Loss-Making Beam Global (NASDAQ:BEEM) Expected To Breakeven In The Medium-Term

Simply Wall St.

10 months ago

Loss-Making Beam Global (NASDAQ:BEEM) Expected To Breakeven In The Medium-Term

U.S. Gold Corp. to Participate at the 2024 Future Minerals Forum in Riyadh, Saudi Arabia

PR Newswire

10 months ago

U.S. Gold Corp. to Participate at the 2024 Future Minerals Forum in Riyadh, Saudi Arabia

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer

GlobeNewswire

10 months ago

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer

Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event

GlobeNewswire

10 months ago

Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event

Cocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational Candidates

GlobeNewswire

10 months ago

Cocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational Candidates

Chamonix, Colorado’s Newest and Most Luxurious Casino Hotel, Opens at Noon on Wednesday, December 27, 2023

GlobeNewswire

a year ago

Chamonix, Colorado’s Newest and Most Luxurious Casino Hotel, Opens at Noon on Wednesday, December 27, 2023

TMC Subsidiary NORI Shares Preliminary Findings on Environmental Impacts of Pilot Nodule Collection System Test

GlobeNewswire

a year ago

TMC Subsidiary NORI Shares Preliminary Findings on Environmental Impacts of Pilot Nodule Collection System Test

Cocrystal Pharma Announces First-Patient-In for Phase 2a Human Challenge Study Evaluating Oral CC-42344 in Pandemic and Seasonal Influenza A

GlobeNewswire

a year ago

Cocrystal Pharma Announces First-Patient-In for Phase 2a Human Challenge Study Evaluating Oral CC-42344 in Pandemic and Seasonal Influenza A

Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to January 3, 2024

GlobeNewswire

a year ago

Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to January 3, 2024

Gain Therapeutics Announces Preclinical Data Showing Restoration of Enzymatic Function with Novel Allosteric Regulators in GM1 Gangliosidosis Model

GlobeNewswire

a year ago

Gain Therapeutics Announces Preclinical Data Showing Restoration of Enzymatic Function with Novel Allosteric Regulators in GM1 Gangliosidosis Model

Cocrystal Pharma Highlights its Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast

GlobeNewswire

a year ago

Cocrystal Pharma Highlights its Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast

Cocrystal Pharma to Present at the NobleCon 19 Conference on December 4, 2023

GlobeNewswire

a year ago

Cocrystal Pharma to Present at the NobleCon 19 Conference on December 4, 2023

CPI Aerostructures Receives $4.4M Orders from Embraer for Engine Inlet Assemblies

GlobeNewswire

a year ago

CPI Aerostructures Receives $4.4M Orders from Embraer for Engine Inlet Assemblies

Quantum Computing Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

PR Newswire

a year ago

Quantum Computing Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Zacks Small Cap Research

a year ago

COCP: Cocrystal Pharma reports 3rd quarter financial results and provides updates on clinical trials.

Cocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs

GlobeNewswire

a year ago

Cocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs

Cocrystal Pharma to Discuss Progress with Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast

GlobeNewswire

a year ago

Cocrystal Pharma to Discuss Progress with Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast

CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

PR Newswire

a year ago

CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

Paltalk, Inc. Reports an Increase in Revenue of 5.5% in Third Quarter 2023

GlobeNewswire

a year ago

Paltalk, Inc. Reports an Increase in Revenue of 5.5% in Third Quarter 2023

Billionaire Marc Lasry’s Top 10 Stock Picks

Insider Monkey

a year ago

Billionaire Marc Lasry’s Top 10 Stock Picks

Share on Social Networks: